Company intelligence / Profile preview

Emblem Cannabis

Paris, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Emblem Cannabis supplied commercially available pharmaceutical-grade medical cannabis oils and dried flowers for a range of chronic and acute medical conditions in Canada until its acquisition; the company focused on cultivar-specific extracts for product consistency, patient-tailored care, and had two production and R&D facilities in Ontario[1][4].

Therapeutic areas: GastroenterologyOncologyNeurologyPsychiatry
Modalities: Plant-derived product
Industry: Biotech

Partnerships

Aphria (supply agreement)Compass Cannabis ClinicAcnos Pharma (Germany JV)Canabo Medical Clinic

Beyond the preview

Go deeper on Emblem Cannabis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emblem Cannabis.

Explore the full profile